Molecular and epidemiological characterization of imported malaria cases in Chile

Simple item page
dc.coverageDOI: 10.1186/s12936-020-03353-y
dc.creatorEscobar, Daniel F.
dc.creatorLucchi, Naomi W.
dc.creatorAbdallah, Rispah
dc.creatorValenzuela, María Teresa
dc.creatorUdhayakumar, Venkatachalam
dc.creatorJercic, María Isabel
dc.creatorChenet, Stella M.
dc.date2020
dc.date.accessioned2025-11-18T19:53:54Z
dc.date.available2025-11-18T19:53:54Z
dc.description<p>Background: Chile is one of the South American countries certified as malaria-free since 1945. However, the recent increase of imported malaria cases and the presence of the vector Anopheles pseudopunctipennis in previously endemic areas in Chile require an active malaria surveillance programme. Methods: Specimens from 268 suspected malaria cases - all imported - collected between 2015 and 2018 at the Public Health Institute of Chile (ISP), were diagnosed by microscopy and positive cases were included for epidemiological analysis. A photo-induced electron transfer fluorogenic primer real-time PCR (PET-PCR) was used to confirm the presence of malaria parasites in available blood samples. Sanger sequencing of drug resistance molecular markers (pfk13, pfcrt and pfmdr1) and microsatellite (MS) analysis were performed in confirmed Plasmodium falciparum samples and results were related to origin of infection. Results: Out of the 268 suspected cases, 65 were Plasmodium spp. positive by microscopy. A total of 63% of the malaria patients were male and 37% were female; 43/65 of the patients acquired infections in South American endemic countries. Species confirmation of available blood samples by PET-PCR revealed that 15 samples were positive for P. falciparum, 27 for Plasmodium vivax and 4 were mixed infections. The P. falciparum samples sequenced contained four mutant pfcrt genotypes (CVMNT, CVMET, CVIET and SVMNT) and three mutant pfmdr1 genotypes (Y184F/S1034C/N1042D/D1246Y, Y184F/N1042D/D1246Y and Y184F). MS analysis confirmed that all P. falciparum samples presented different haplotypes according to the suspected country of origin. Four patients with P. vivax infection returned to the health facilities due to relapses. Conclusion: The timely detection of polymorphisms associated with drug resistance will contribute to understanding if current drug policies in the country are appropriate for treatment of imported malaria cases and provide information about the most frequent resistant genotypes entering Chile.</p>eng
dc.descriptionBackground: Chile is one of the South American countries certified as malaria-free since 1945. However, the recent increase of imported malaria cases and the presence of the vector Anopheles pseudopunctipennis in previously endemic areas in Chile require an active malaria surveillance programme. Methods: Specimens from 268 suspected malaria cases - all imported - collected between 2015 and 2018 at the Public Health Institute of Chile (ISP), were diagnosed by microscopy and positive cases were included for epidemiological analysis. A photo-induced electron transfer fluorogenic primer real-time PCR (PET-PCR) was used to confirm the presence of malaria parasites in available blood samples. Sanger sequencing of drug resistance molecular markers (pfk13, pfcrt and pfmdr1) and microsatellite (MS) analysis were performed in confirmed Plasmodium falciparum samples and results were related to origin of infection. Results: Out of the 268 suspected cases, 65 were Plasmodium spp. positive by microscopy. A total of 63% of the malaria patients were male and 37% were female; 43/65 of the patients acquired infections in South American endemic countries. Species confirmation of available blood samples by PET-PCR revealed that 15 samples were positive for P. falciparum, 27 for Plasmodium vivax and 4 were mixed infections. The P. falciparum samples sequenced contained four mutant pfcrt genotypes (CVMNT, CVMET, CVIET and SVMNT) and three mutant pfmdr1 genotypes (Y184F/S1034C/N1042D/D1246Y, Y184F/N1042D/D1246Y and Y184F). MS analysis confirmed that all P. falciparum samples presented different haplotypes according to the suspected country of origin. Four patients with P. vivax infection returned to the health facilities due to relapses. Conclusion: The timely detection of polymorphisms associated with drug resistance will contribute to understanding if current drug policies in the country are appropriate for treatment of imported malaria cases and provide information about the most frequent resistant genotypes entering Chile.spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/69c908a7-1915-4817-9d3d-664b0ebbb9e6
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/58491
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.19 (2020) date: 2020-08-13 nr.1
dc.subjectChile
dc.subjectMalaria
dc.subjectMicrosatellites
dc.subjectPCR
dc.subjectSurveillance
dc.subjectpfcrt
dc.subjectpfmdr1
dc.subjectChile
dc.subjectMalaria
dc.subjectMicrosatellites
dc.subjectPCR
dc.subjectpfcrt
dc.subjectpfmdr1
dc.subjectSurveillance
dc.subjectSDG 3 - Good Health and Well-being
dc.titleMolecular and epidemiological characterization of imported malaria cases in Chileeng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE